Stayble Therapeutics (Sweden) Analysis
| STABL Stock | SEK 0.41 0.01 2.50% |
Stayble Therapeutics AB is overvalued with Real Value of 0.36 and Hype Value of 0.41. The main objective of Stayble Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Stayble Therapeutics AB is worth, separate from its market price. There are two main types of Stayble Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Stayble Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Stayble Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Stayble Therapeutics stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Stayble Therapeutics is usually not traded on Good Friday, Epiphany, Easter Sunday, Easter Monday, International Workers ' Day, NationalDay, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day. Stayble Stock trading window is adjusted to Europe/Stockholm timezone.
Stayble |
Stayble Stock Analysis Notes
About 33.0% of the company outstanding shares are owned by corporate insiders. The book value of Stayble Therapeutics was at this time reported as 1.43. The company recorded a loss per share of 1.27. Stayble Therapeutics had not issued any dividends in recent years. Stayble Therapeutics AB develops injectable treatment for chronic low back pain triggered by disc degeneration. Stayble Therapeutics AB is based in Gothenburg, Sweden. Stayble Therapeutics is traded on Stockholm Stock Exchange in Sweden. To find out more about Stayble Therapeutics AB contact Andreas MSc at 46 7 30 80 83 97 or learn more at https://www.staybletherapeutics.se.Stayble Therapeutics Investment Alerts
| Stayble Therapeutics generated a negative expected return over the last 90 days | |
| Stayble Therapeutics has high historical volatility and very poor performance | |
| Stayble Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (12.09 M) with profit before overhead, payroll, taxes, and interest of 9 K. | |
| Stayble Therapeutics AB has accumulated about 42.71 M in cash with (9.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 33.0% of the company outstanding shares are owned by corporate insiders |
Stayble Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Stayble Therapeutics's market, we take the total number of its shares issued and multiply it by Stayble Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 21st of July, Stayble Therapeutics has the Variance of 35.9, risk adjusted performance of (0.01), and Coefficient Of Variation of (4,571). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stayble Therapeutics, as well as the relationship between them. Please validate Stayble Therapeutics mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Stayble Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 0.41 per share.Stayble Therapeutics Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Stayble Therapeutics for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Stayble Therapeutics short-term fluctuations and highlight longer-term trends or cycles.
Stayble Therapeutics Outstanding Bonds
Stayble Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Stayble Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Stayble bonds can be classified according to their maturity, which is the date when Stayble Therapeutics AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Stayble Therapeutics Predictive Daily Indicators
Stayble Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Stayble Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Stayble Therapeutics Forecast Models
Stayble Therapeutics' time-series forecasting models are one of many Stayble Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Stayble Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Stayble Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Stayble Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Stayble shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Stayble Therapeutics. By using and applying Stayble Stock analysis, traders can create a robust methodology for identifying Stayble entry and exit points for their positions.
Stayble Therapeutics AB develops injectable treatment for chronic low back pain triggered by disc degeneration. Stayble Therapeutics AB is based in Gothenburg, Sweden. Stayble Therapeutics is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Stayble Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Additional Tools for Stayble Stock Analysis
When running Stayble Therapeutics' price analysis, check to measure Stayble Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stayble Therapeutics is operating at the current time. Most of Stayble Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stayble Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stayble Therapeutics' price. Additionally, you may evaluate how the addition of Stayble Therapeutics to your portfolios can decrease your overall portfolio volatility.